Cutaneous leishmaniasis is a skin disease caused by protozoa of the genus Leishmania , which is endemic in tropical and subtropical regions, with Leishmania infantum becoming increasingly relevant in southern Europe, particularly in the Mediterranean region. This pathogen typically causes visceral leishmaniasis, but can also cause exclusively cutaneous lesions in immunocompetent individuals, as in the present case.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Atopic Dermatitis: Precisely Targeting Immunological Targets
Interleukin blockade or OX40-(L) inhibition?
- Fibromyalgia Syndrome
Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
- Across All Types of Cancer
Four-Legged Medical Assistants – Therapy Dogs in Clinical Settings
- Obesity: More than half of those affected have fatty liver disease
From screening to multimodal intervention with GLP-1-RA or resmetirom
- Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib
First-class immunomodulation combined with convenience—the data available so far is convincing
- Preclinical Study on a Special Ginkgo biloba Extract
What role do proanthocyanidins play?
- Myasthenia gravis: immunomodulatory therapies for long-term treatment
Expanded Possibilities Thanks to Innovative Classes of Active Ingredients
- Plastic surgery and reconstructive microsurgery for DFS